home / stock / nhwk / nhwk news

NHWK News and Press, NightHawk Biosciences Inc. From 06/13/22

Stock Information
Company Name: NightHawk Biosciences Inc.
Stock Symbol: NHWK
Market: NYSE
Menu
NHWK NHWK Quote NHWK Short NHWK News NHWK Articles NHWK Message Board
Get NHWK Alerts

News, Short Squeeze, Breakout and More Instantly...
NHWK - NightHawk Biosciences Appoints Stephan Kutzer, Ph.D. as Interim Chief Executive Officer of Scorpion Biological Services

DURHAM, N.C., June 13, 2022 (GLOBE NEWSWIRE) -- NightHawk Biosciences (NYSE American: NHWK) , a fully integrated biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced the appointment of Stephan Kutzer, Ph.D. as Interi...
NHWK - NightHawk Biosciences GAAP EPS of -$0.32 beats by $0.17

NightHawk Biosciences press release (NYSE:NHWK): Q1 GAAP EPS of -$0.32 beats by $0.17. Recognized $0.2 million of grant revenue for qualified expenditures under the CPRIT grant for the quarter ended March 31, 2022 compared to $0.5 million for the quarter ended March 31, 2021. For further de...

NHWK - NightHawk Biosciences Provides First Quarter 2022 Business Update

DURHAM, N.C., May 16, 2022 (GLOBE NEWSWIRE) -- NightHawk Biosciences (NYSE American: NHWK) , a fully integrated biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today provided strategic, financial, and operational updates fo...

NHWK - NightHawk Biosciences to Present at the 4th Annual Treg Directed Therapies Summit on PTX-35

DURHAM, N.C., May 10, 2022 (GLOBE NEWSWIRE) -- NightHawk Biosciences (NYSE American: NHWK) , a fully integrated biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced that Matthew Seavey, Ph.D., MBA, NightHawk ...
Previous 10 Next 10